Paul J. Yazaki

5.2k total citations
102 papers, 3.4k citations indexed

About

Paul J. Yazaki is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Molecular Biology. According to data from OpenAlex, Paul J. Yazaki has authored 102 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Radiology, Nuclear Medicine and Imaging, 51 papers in Oncology and 28 papers in Molecular Biology. Recurrent topics in Paul J. Yazaki's work include Radiopharmaceutical Chemistry and Applications (37 papers), Monoclonal and Polyclonal Antibodies Research (37 papers) and Cancer Research and Treatments (21 papers). Paul J. Yazaki is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (37 papers), Monoclonal and Polyclonal Antibodies Research (37 papers) and Cancer Research and Treatments (21 papers). Paul J. Yazaki collaborates with scholars based in United States, Japan and Sweden. Paul J. Yazaki's co-authors include Karl Y. Hostetler, Anna M. Wu, John E. Shively, Andrew Raubitschek, Lawrence E. Williams, Jeffrey Y.C. Wong, B. J. H. M. Poorthuis, David Colcher, Sanjiv S. Gambhir and C W Cheung and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Blood.

In The Last Decade

Paul J. Yazaki

99 papers receiving 3.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paul J. Yazaki United States	33	1.7k	1.3k	1.1k	461	439	102	3.4k
Wijnand Helfrich Netherlands	38	998 0.6×	1.7k 1.3×	1.2k 1.1×	1.4k 3.0×	389 0.9×	114	3.7k
Vikas Kundra United States	32	781 0.5×	1.9k 1.4×	667 0.6×	282 0.6×	805 1.8×	113	4.0k
Leslie A. Khawli United States	34	2.0k 1.2×	1.7k 1.3×	1.1k 1.0×	1.0k 2.2×	164 0.4×	92	3.5k
Jan Mařı́k United States	30	1.3k 0.8×	1.2k 0.9×	671 0.6×	221 0.5×	236 0.5×	71	2.7k
Robert Waibel Switzerland	27	1.6k 0.9×	1.2k 0.9×	862 0.8×	459 1.0×	349 0.8×	78	3.0k
Delia Mezzanzanica Italy	37	897 0.5×	2.0k 1.5×	1.3k 1.2×	1.0k 2.2×	242 0.6×	107	3.9k
Alan Alfieri United States	28	595 0.3×	816 0.6×	584 0.6×	278 0.6×	523 1.2×	66	2.6k
Shawn E. Lupold United States	26	539 0.3×	2.6k 2.0×	798 0.8×	211 0.5×	696 1.6×	58	3.9k
Ryan J. Park United States	29	1.3k 0.8×	1.2k 0.9×	744 0.7×	170 0.4×	277 0.6×	59	3.0k
Rebecca S. Cook United States	37	656 0.4×	2.7k 2.0×	2.1k 2.0×	1.0k 2.2×	601 1.4×	73	4.9k

Countries citing papers authored by Paul J. Yazaki

Since Specialization

Citations

This map shows the geographic impact of Paul J. Yazaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul J. Yazaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul J. Yazaki more than expected).

Fields of papers citing papers by Paul J. Yazaki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul J. Yazaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul J. Yazaki. The network helps show where Paul J. Yazaki may publish in the future.

Co-authorship network of co-authors of Paul J. Yazaki

This figure shows the co-authorship network connecting the top 25 collaborators of Paul J. Yazaki. A scholar is included among the top collaborators of Paul J. Yazaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul J. Yazaki. Paul J. Yazaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hong, Teresa, Patty Wong, Susanta Hui, et al.. (2025). Development and Potent Anti-Tumor Activity of a Fully Humanized Anti-TAG-72-IL-2 Fusion Protein for Therapy of Solid Tumors. Cancers. 17(9). 1453–1453.

Lee, Kyung Ha, Kristin E. Cox, Shanglei Liu, et al.. (2024). Accurate Co-Localization of Luciferase Expression and Fluorescent Anti-CEA Antibody Targeting of Liver Metastases in an Orthotopic Mouse Model of Colon Cancer. Cancers. 16(19). 3341–3341. 3 indexed citations

Kujawski, Maciej, Dennis Awuah, Edward Seung, et al.. (2024). Targeting CEA in metastatic triple negative breast cancer with image-guided radiation followed by Fab-mediated chimeric antigen receptor (CAR) T-cell therapy. Frontiers in Immunology. 15. 1499471–1499471. 1 indexed citations

Salazar, Felix B., Masoud Farshbaf, Teresa Hong, et al.. (2024). Abstract A088: Radiopharmaceutical therapy for pancreatic cancer: Engineered anti-prostate stem cell antigen (PSCA) antibody demonstrates targeted imaging and antitumor effects in a syngeneic mouse model of pancreatic ductal adenocarcinoma (PDAC). Cancer Research. 84(2_Supplement). A088–A088. 2 indexed citations

Hernandez, Matthew C., Paul J. Yazaki, Joanne Mortimer, et al.. (2023). Pilot study of HER2 targeted 64Cu-DOTA-tagged PET imaging in gastric cancer patients. Nuclear Medicine Communications. 44(12). 1151–1155. 4 indexed citations

Yazaki, Paul J., Patty Wong, Teresa Hong, et al.. (2023). Generation of IL‐2‐Fc‐antibody conjugates by click chemistry. Biotechnology Journal. 18(9). e2300115–e2300115. 5 indexed citations

Wong, Jeffrey Y.C., Vikram Adhikarla, Paul Frankel, et al.. (2022). First-In-Human Pilot PET Immunoimaging Study of ⁶⁴ Cu-Anti-Carcinoembryonic Antigen Monoclonal Antibody (hT84.66-M5A) in Patients with Carcinoembryonic Antigen-Producing Cancers. Cancer Biotherapy and Radiopharmaceuticals. 38(1). 26–37. 9 indexed citations

Kujawski, Maciej, et al.. (2022). Improved Tumor Responses with Sequential Targeted α-Particles Followed by Interleukin 2 Immunocytokine Therapies in Treatment of CEA-Positive Breast and Colon Tumors in CEA Transgenic Mice. Journal of Nuclear Medicine. 63(12). 1859–1864. 8 indexed citations

Seung, Edward, Maciej Kujawski, Paul J. Yazaki, Christine E. Brown, & John E. Shively. (2021). Tumor regression and immunity in combination therapy with anti-CEA chimeric antigen receptor T cells and anti-CEA-IL2 immunocytokine. OncoImmunology. 10(1). 1899469–1899469. 34 indexed citations

10.

Kujawski, Maciej, Mark E. Sherman, Susanta Hui, et al.. (2020). Potent immunomodulatory effects of an anti-CEA-IL-2 immunocytokine on tumor therapy and effects of stereotactic radiation. OncoImmunology. 9(1). 1724052–1724052. 17 indexed citations

11.

Li, Lin, Paul J. Yazaki, Junie Chea, et al.. (2020). Improved targeting of an anti‐TAG‐72 antibody drug conjugate for the treatment of ovarian cancer. Cancer Medicine. 9(13). 4756–4767. 15 indexed citations

12.

Wong, Patty, Lin Li, Junie Chea, et al.. (2020). Antibody Targeted PET Imaging of ⁶⁴Cu-DOTA-Anti-CEA PEGylated Lipid Nanodiscs in CEA Positive Tumors. Bioconjugate Chemistry. 31(3). 743–753. 18 indexed citations

13.

Kujawski, Maciej, Lin Li, S. Bhattacharya, et al.. (2019). Generation of dual specific bivalent BiTEs (dbBIspecific T-cell engaging antibodies) for cellular immunotherapy. BMC Cancer. 19(1). 882–882. 17 indexed citations

14.

Leong, Lucille, Lawrence D. Wagman, Stephen Shibata, et al.. (2017). Phase I/II Trial of Anticarcinoembryonic Antigen Radioimmunotherapy, Gemcitabine, and Hepatic Arterial Infusion of Fluorodeoxyuridine Postresection of Liver Metastasis for Colorectal Carcinoma. Cancer Biotherapy and Radiopharmaceuticals. 32(7). 258–265. 11 indexed citations

15.

Wong, Patty, Lin Li, Junie Chea, et al.. (2017). Synthesis, Positron Emission Tomography Imaging, and Therapy of Diabody Targeted Drug Lipid Nanoparticles in a Prostate Cancer Murine Model. Cancer Biotherapy and Radiopharmaceuticals. 32(7). 247–257. 13 indexed citations

16.

Williams, Lawrence E., Anna M. Wu, Vania Kenanova, Tove Olafsen, & Paul J. Yazaki. (2014). Numerical Comparison of Iodine-Based and Indium-Based Antibody Biodistributions. Cancer Biotherapy and Radiopharmaceuticals. 29(3). 91–98. 3 indexed citations

17.

Yazaki, Paul J., Divya Channappa, Chi Wai Cheung, et al.. (2012). A series of anti-CEA/anti-DOTA bispecific antibody formats evaluated for pre-targeting: comparison of tumor uptake and blood clearance. Protein Engineering Design and Selection. 26(3). 187–193. 29 indexed citations

18.

Wong, Jeffrey Y.C., David Z. J. Chu, Lawrence E. Williams, et al.. (2006). A Phase I Trial of ⁹⁰ Y-DOTA-Anti-CEA Chimeric T84.66 (cT84.66) Radioimmunotherapy in Patients with Metastatic CEA-Producing Malignancies. Cancer Biotherapy and Radiopharmaceuticals. 21(2). 88–100. 38 indexed citations

19.

Olafsen, Tove, Vania Kenanova, Gobalakrishnan Sundaresan, et al.. (2005). Optimizing Radiolabeled Engineered Anti-p185HER2 Antibody Fragments for In vivo Imaging. Cancer Research. 65(13). 5907–5916. 123 indexed citations

20.

Williams, Lawrence E., Anna M. Wu, Paul J. Yazaki, et al.. (2001). Numerical Selection of Optimal Tumor Imaging Agents with Application to Engineered Antibodies. Cancer Biotherapy and Radiopharmaceuticals. 16(1). 25–35. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact